Top Analyst Reports for JPMorgan, PayPal & Novo Nordisk
Zacks Investment Research | Sep 18, 2020 03:14AM ET
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase (NYSE:JPM) (JPM), PayPal (PYPL) and Novo Nordisk (NYSE:NVO) (NVO). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see
Today's Must Read/h6
Featured Reports/h6
Per the Zacks analyst, Facebook is benefiting from improving engagement levels for Instagram.
Per the Zacks analyst, Roche maintains momentum propelled by solid sales of new drugs like Ocrevus, Tecentriq and Hemlibra.
Strategic alliances with Subaru and Mazda are likely to drive Toyota's ambitious electrification goals and boost its growth prospects, per the Zacks analyst.
ExxonMobil estimates gross recoverable resources of more than 8 billion oil-equivalent barrels from offshore Guyana discoveries. However, weak refining business concerns the Zacks analyst.
Per the Zacks analyst, Altria is set to gain on efforts to expand oral tobacco products unit, wherein revenues rose 9.6% in second quarter.
Per the Zacks analyst, significant reduction in costs, primarily due to increased operational efficiency and low fuel prices, are keeping CSX afloat amid coronavirus-led weakness in volumes.
Per the Zacks analyst, Stanley Black (SWK) is poised to benefit from growing recognition for do-it-yourself products as well as those related to security and health.
Per the Zacks analyst, Facebook is benefiting from improving engagement levels for Instagram.
Per the Zacks analyst, Roche maintains momentum propelled by solid sales of new drugs like Ocrevus, Tecentriq and Hemlibra.
Strategic alliances with Subaru and Mazda are likely to drive Toyota's ambitious electrification goals and boost its growth prospects, per the Zacks analyst.
ExxonMobil estimates gross recoverable resources of more than 8 billion oil-equivalent barrels from offshore Guyana discoveries. However, weak refining business concerns the Zacks analyst.
Per the Zacks analyst, Altria is set to gain on efforts to expand oral tobacco products unit, wherein revenues rose 9.6% in second quarter.
Per the Zacks analyst, significant reduction in costs, primarily due to increased operational efficiency and low fuel prices, are keeping CSX afloat amid coronavirus-led weakness in volumes.
Per the Zacks analyst, Stanley Black (SWK) is poised to benefit from growing recognition for do-it-yourself products as well as those related to security and health.
New Upgrades/h6
The Zacks analyst lauds the uptick in revenues at FedEx's (FDX) Ground unit (up 36% in first-quarter fiscal 2021). Residential-delivery volume growth in the current scenario is aiding results.
Per the Zacks analyst, Lennar is poised to benefit from prudent land investment strategies, strength in the housing market and operating efficiency.
Per the Zacks analyst, consumers' shifting preference for essential items is benefiting Newell Brands' Food business segment. Also, robust e-commerce sales and Project FUEL plan act as growth drivers.
The Zacks analyst lauds the uptick in revenues at FedEx's (FDX) Ground unit (up 36% in first-quarter fiscal 2021). Residential-delivery volume growth in the current scenario is aiding results.
Per the Zacks analyst, Lennar is poised to benefit from prudent land investment strategies, strength in the housing market and operating efficiency.
Per the Zacks analyst, consumers' shifting preference for essential items is benefiting Newell Brands' Food business segment. Also, robust e-commerce sales and Project FUEL plan act as growth drivers.
New Downgrades/h6
Per the Zacks Analyst, Micron's near-term performance might be hurt by the bleak memory chip demand as customers are adjusting inventories in response to the economic recession caused by COVID-19.
According to the Zacks analyst, soft industrial demand due to reduced customer activities in the wake of the coronavirus pandemic will hurt the company's sales volumes.
The Zacks analyst believes that USA Compression Partners' high debt-to-capitalization of 67% is a concern. Further, the coronavirus-induced decline in volumes is likely to result in lower profits.
Per the Zacks Analyst, Micron's near-term performance might be hurt by the bleak memory chip demand as customers are adjusting inventories in response to the economic recession caused by COVID-19.
According to the Zacks analyst, soft industrial demand due to reduced customer activities in the wake of the coronavirus pandemic will hurt the company's sales volumes.
The Zacks analyst believes that USA Compression Partners' high debt-to-capitalization of 67% is a concern. Further, the coronavirus-induced decline in volumes is likely to result in lower profits.
Get The News You Want
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Zacks Investment Research
/h3
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.